December 7, 2022 Marc Blaustein mblaustein@finchtherapeutics.com Dear Marc,Employment Agreement • March 23rd, 2023 • Finch Therapeutics Group, Inc. • Biological products, (no disgnostic substances)
The purpose of this letter is to amend the Employment Agreement by and between Finch Therapeutics Group, Inc. (the “Company”) and you dated as of September 8, 2021 (the “Employment Agreement”), effective as of April 30, 2022 (the “Effective Date”). Capitalized terms used but not defined in this letter will have the meanings set forth in the Employment Agreement.
RETENTION BONUS AGREEMENTRetention Bonus Agreement • March 23rd, 2023 • Finch Therapeutics Group, Inc. • Biological products, (no disgnostic substances) • Massachusetts
THIS RETENTION BONUS AGREEMENT (this “Agreement”), is made and entered into by and between Finch Therapeutics Group, Inc., a Delaware corporation (together with all subsidiaries and affiliates hereinafter referred to as the “Company”), and Marc Blaustein (the “Executive”) effective as of December 7, 2022.
